Literature DB >> 1376108

Structural and computational investigations of the conformation of antigenic peptide fragments of human polymorphic epithelial mucin.

M J Scanlon1, S D Morley, D E Jackson, M R Price, S J Tendler.   

Abstract

Human polymorphic epithelial mucins (PEM) are complex glycoproteins that are associated with breast and ovarian carcinomas. The PEM core protein consists of variable numbers of a tandem repeat sequence which contains a short antigenic hydrophilic region (Pro1-Asp-Thr-Arg-Pro-Ala-Pro7). High-field n.m.r. studies undertaken on antigenic 20- and 11-amino acid fragments of the PEM core protein in dimethyl sulphoxide have identified a type-I beta-turn to be present in the region Pro1-Asp-Thr-Arg4. This region includes and overlaps the identified type-I (Asp2-Thr-Arg4) and type-II (Arg4-Pro-Ala6) epitopes of anti-PEM monoclonal antibodies. The studies indicate that the beta-turn is stabilized by the presence of a salt-bridge interaction between Asp-2 and Arg-4. In order to probe the conformations accessible to the PEM peptides a computational study was undertaken independently on the peptide Pro-Asp-Thr-Arg-Pro using a modified Metropolis Monte Carlo algorithm. This study identified the n.m.r.-observed salt-bridge type-I beta-turn as the major low-energy conformer. These results suggest that this structural motif may be involved in the immune recognition of PEM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376108      PMCID: PMC1132708          DOI: 10.1042/bj2840137

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Charge calculations in molecular mechanics. Part 8. Partial atomic charges from classical calculations.

Authors:  R J Abraham; G H Grant; I S Haworth; P E Smith
Journal:  J Comput Aided Mol Des       Date:  1991-02       Impact factor: 3.686

2.  1H-NMR assignment and secondary structure of a herpes simplex virus glycoprotein D-1 antigenic domain.

Authors:  M P Williamson; M J Hall; B K Handa
Journal:  Eur J Biochem       Date:  1986-08-01

3.  Strategic approaches to drug design. I. An integrated software framework for molecular modelling.

Authors:  J G Vinter; A Davis; M R Saunders
Journal:  J Comput Aided Mol Des       Date:  1987-04       Impact factor: 3.686

4.  Modification of available arginine residues in proteins by p-hydroxyphenylglyoxal.

Authors:  R B Yamasaki; A Vega; R E Feeney
Journal:  Anal Biochem       Date:  1980-11-15       Impact factor: 3.365

5.  1H and 15N NMR studies of protonation and hydrogen-bonding in the binding of trimethoprim to dihydrofolate reductase.

Authors:  A W Bevan; G C Roberts; J Feeney; L Kuyper
Journal:  Eur Biophys J       Date:  1985       Impact factor: 1.733

6.  Immunological and structural features of the protein core of human polymorphic epithelial mucin.

Authors:  M R Price; F Hudecz; C O'Sullivan; R W Baldwin; P M Edwards; S J Tendler
Journal:  Mol Immunol       Date:  1990-08       Impact factor: 4.407

7.  Elements of secondary structure in a human epithelial mucin core peptide fragment.

Authors:  S J Tendler
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

8.  A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

Authors:  S Gendler; J Taylor-Papadimitriou; T Duhig; J Rothbard; J Burchell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

9.  COSMIC(90): an improved molecular mechanics treatment of hydrocarbons and conjugated systems.

Authors:  S D Morley; R J Abraham; I S Haworth; D E Jackson; M R Saunders; J G Vinter
Journal:  J Comput Aided Mol Des       Date:  1991-10       Impact factor: 3.686

10.  Detection of the urinary 'PUM' polymorphism by the tumour-binding monoclonal antibodies Ca1, Ca2, Ca3, HMFG1, and HMFG2.

Authors:  D M Swallow; B Griffiths; M Bramwell; G Wiseman; J Burchell
Journal:  Dis Markers       Date:  1986-12       Impact factor: 3.434

View more
  3 in total

1.  Construction of a reshaped HMFG1 antibody and comparison of its fine specificity with that of the parent mouse antibody.

Authors:  M E Verhoeyen; J A Saunders; M R Price; J D Marugg; S Briggs; E L Broderick; S J Eida; A T Mooren; R A Badley
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

2.  Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.

Authors:  Mohammadreza Movahedin; Teresa M Brooks; Nitin T Supekar; Naveen Gokanapudi; Geert-Jan Boons; Cory L Brooks
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

3.  Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.

Authors:  X Liu; J Sejbal; G Kotovych; R R Koganty; M A Reddish; L Jackson; S S Gandhi; A J Mendonca; B M Longenecker
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.